ZERBONI, GIULIA
ZERBONI, GIULIA
Cutaneous manifestations and gastrointestinal disorders. report of two emblematic cases
2015 Carlesimo, Marta; Abruzzese, Claudia; Narcisi, Alessandra; Margagnoni, Giovanna; Zerboni, Giulia; Purchiaroni, Flaminia; Pagnini, Cristiano; DI GIULIO, Emilio; Corleto, Vito Domenico
Early onset pancreatic cancer. Risk factors, presentation and outcome
2015 Piciucchi, Matteo; Valente, Roberto; LA TORRE, Marco; Cavallini, Marco; G., Costamagna; Ziparo, Vincenzo; DELLE FAVE, Gianfranco; Capurso, Gabriele; Larghi, Alberto; Archibugi, Livia; Signoretti, Marianna; Stigliano, Serena; Zerboni, Giulia; Barucca, Viola; Marchetti, Paolo
Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study
2018 Valente, Roberto; Crippa, Stefano; Vanella, Giuseppe; Zerboni, Giulia; Fogliati, Alessandro; Arnelo, Urban; Falconi, Massimo; Capurso, Gabriele; Del Chiaro, Marco
Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease. An ECCO CONFER Multicentre Case Series
2022 Festa, Stefano; Zerboni, Giulia; Derikx, Lauranne A A P; Ribaldone, Davide Giuseppe; Dragoni, Gabriele; Buskens, Christianne; van Dijkum, Els Nieveen; Pugliese, Daniela; Panzuto, Francesco; Krela-Kaźmierczak, Iwona; Mintz, Hilla Reiss; Shitrit, Ariella Bar-Gil; Chaparro, Marìa; Gisbert, Javier P; Kopylov, Uri; Teich, Niels; Vainer, Elez; Nagtegaal, Iris; Hoentjen, Frank; Garcia, Maria Jose; Filip, Rafal; Foteinogiannopoulou, Kalliopi; Koutroubakis, Ioannis E; Argollo, Marjorie; van Wanrooij, Roy L J; Laja, Hendrik; Lobaton, Triana; Truyens, Marie; Molnar, Tamas; Savarino, Edoardo; Aratari, Annalisa; Papi, Claudio; Goren, Idan
P.04.12 ROLE OF CYST FEATURES AND PATIENTS' FACTORS IN PREDICTING THE RISK OF PROGRESSION IN BD-IPMN UNDERGOING FOLLOW-UP
2018 Zerboni, G.; Vanella, G.; Stigliano, S.; Archibugi, L.; Signoretti, M.; Valente, R.; Iannicelli, E.; Fave, G. Delle; Capurso, G.
The baseline nutritional status assessed by MUST score has a low accuracy in predicting the risk of hospitalization during follow-up in patients with chronic pancreatitis: A cohort study: CP nutritional status and complications
2020 Stigliano, S.; Archibugi, L.; Signoretti, M.; Zerboni, G.; Capurso, G.
The neutrophil/lymphocyte ratio at diagnosis is significantly associated with survival in metastatic pancreatic cancer patients
2017 Piciucchi, M; Stigliano, Serena; Archibugi, Livia; Zerboni, Giulia; Signoretti, Marianna; Barucca, Viola; Valente, Roberto; DELLE FAVE, Gianfranco; Capurso, G. 9.
The prevalence of pancreatic cystic lesions in patients with liver cirrhosis is double that in controls
2017 Zerboni, G.; Capurso, G.; Di Pietropaolo, M.; Carbonetti, F.; Iannicelli, E.; Marignani, M.; Delle Fave, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Cutaneous manifestations and gastrointestinal disorders. report of two emblematic cases | 2015 | Carlesimo, Marta; Abruzzese, Claudia; Narcisi, Alessandra; Margagnoni, Giovanna; Zerboni, Giulia; Purchiaroni, Flaminia; Pagnini, Cristiano; DI GIULIO, Emilio; Corleto, Vito Domenico | |
| Early onset pancreatic cancer. Risk factors, presentation and outcome | 2015 | Piciucchi, Matteo; Valente, Roberto; LA TORRE, Marco; Cavallini, Marco; G., Costamagna; Ziparo, Vincenzo; DELLE FAVE, Gianfranco; Capurso, Gabriele; Larghi, Alberto; Archibugi, Livia; Signoretti, Marianna; Stigliano, Serena; Zerboni, Giulia; Barucca, Viola; Marchetti, Paolo | |
| Effect of aspirin, ACE inhibitors/sartans and statins use on the progression of BD-IPMN in follow up: a multicenter study | 2018 | Valente, Roberto; Crippa, Stefano; Vanella, Giuseppe; Zerboni, Giulia; Fogliati, Alessandro; Arnelo, Urban; Falconi, Massimo; Capurso, Gabriele; Del Chiaro, Marco | |
| Gastroenteropancreatic Neuroendocrine Neoplasms in Patients with Inflammatory Bowel Disease. An ECCO CONFER Multicentre Case Series | 2022 | Festa, Stefano; Zerboni, Giulia; Derikx, Lauranne A A P; Ribaldone, Davide Giuseppe; Dragoni, Gabriele; Buskens, Christianne; van Dijkum, Els Nieveen; Pugliese, Daniela; Panzuto, Francesco; Krela-Kaźmierczak, Iwona; Mintz, Hilla Reiss; Shitrit, Ariella Bar-Gil; Chaparro, Marìa; Gisbert, Javier P; Kopylov, Uri; Teich, Niels; Vainer, Elez; Nagtegaal, Iris; Hoentjen, Frank; Garcia, Maria Jose; Filip, Rafal; Foteinogiannopoulou, Kalliopi; Koutroubakis, Ioannis E; Argollo, Marjorie; van Wanrooij, Roy L J; Laja, Hendrik; Lobaton, Triana; Truyens, Marie; Molnar, Tamas; Savarino, Edoardo; Aratari, Annalisa; Papi, Claudio; Goren, Idan | |
| P.04.12 ROLE OF CYST FEATURES AND PATIENTS' FACTORS IN PREDICTING THE RISK OF PROGRESSION IN BD-IPMN UNDERGOING FOLLOW-UP | 2018 | Zerboni, G.; Vanella, G.; Stigliano, S.; Archibugi, L.; Signoretti, M.; Valente, R.; Iannicelli, E.; Fave, G. Delle; Capurso, G. | |
| The baseline nutritional status assessed by MUST score has a low accuracy in predicting the risk of hospitalization during follow-up in patients with chronic pancreatitis: A cohort study: CP nutritional status and complications | 2020 | Stigliano, S.; Archibugi, L.; Signoretti, M.; Zerboni, G.; Capurso, G. | |
| The neutrophil/lymphocyte ratio at diagnosis is significantly associated with survival in metastatic pancreatic cancer patients | 2017 | Piciucchi, M; Stigliano, Serena; Archibugi, Livia; Zerboni, Giulia; Signoretti, Marianna; Barucca, Viola; Valente, Roberto; DELLE FAVE, Gianfranco; Capurso, G. 9. | |
| The prevalence of pancreatic cystic lesions in patients with liver cirrhosis is double that in controls | 2017 | Zerboni, G.; Capurso, G.; Di Pietropaolo, M.; Carbonetti, F.; Iannicelli, E.; Marignani, M.; Delle Fave, G. |